Our recent studies showed that tumor-promoting phorbol ester TPA could stabilize CK1ε, enhance its kinase activity, induce LRP6 phosphorylation at Thr1479 and Ser1490, finally leading to activation of the Wnt/β-catenin pathway [10]. The gene discussed is LRP6; the disease is neoplasm.